ClinicalTrials.gg
CompletedNCT03053245m-CCRPUpdated Jun 24, 2024Results posted

Mobile Critical Care Recovery Program for Acute Respiratory Failure Survivors

An interventional study of Mobile Critical Care Program and Attention Control in Acute Respiratory Failure and Post-Intensive Care Syndrome, sponsored by Indiana University. Completed at 3 sites in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-06-24.

Sponsored by Indiana University · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
503
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The m-CCRP randomized controlled trial will evaluate the efficacy of a collaborative critical care recovery program from acute respiratory failure (ARF) survivors in accomplishing the Institute of Healthcare Improvement's triple aims of better health, better care, at lower cost.

Primary Aim:

To assess the efficacy of m-CCRP in improving the QOL of ARF survivors compared to attention control at twelve months post hospital discharge.

Secondary Aims:

  1. To evaluate the efficacy of m-CCRP in improving cognitive, physical, and psychological function of ARF survivors at twelve months post hospital discharge when compared to attention control.
  2. To evaluate the efficacy of m-CCRP in reducing health-care utilization, defined as time from enrollment to emergency department visits and/or hospital re-admission, by ARF survivors as compared to attention control at twelve months post hospital discharge.
Read the detailed description

Five million Americans require admission to intensive care units (ICU) annually due to life threatening illnesses, and this number is expected to rise.4 Two million of these ICU admissions are secondary to Acute Respiratory Failure (ARF) with more than half requiring mechanical ventilation. Greater than 50% of the patients with ARF who survive their ICU stay suffer from long-term morbidity in the form of functional disability, cognitive disability, major or minor depression, and anxiety. These complications negatively impact the quality of life (QOL) of ARF survivors, interfere with their physical and emotional recovery, and lead to long-term disability with less than half of ARF survivors returning to the work force. Ongoing care for ARF survivors has been estimated to cost $3.5 million per ARF survivor at 1 year. This constellation of ICU sequelae with attendant morbidity has been designated as the post-intensive care syndrome (PICS). There are community resources and rehabilitation services available to ARF survivors, but the current fragmented nature of our healthcare system is unable to integrate and coordinate care in order to provide the most meaningful recovery.

The Institute of Medicine recommends the development of care coordination programs to deliver patient-centered and interdisciplinary-based medical care. Indiana University Center for Aging Research (IUCAR) has over 20 years of experience in delivering interdisciplinary, collaborative care through pragmatic interventions utilizing care coordinators. Care coordinator delivery models have improved care of patients with dementia, depression, functional decline and PICS. Our PICS clinic, the Critical Care Recovery Center (CCRC) was developed in 2011 to enhance cognitive, physical, and psychological recovery of ICU survivors.

Since then, CCRC has provided care to over 200 survivors with a high burden of PICS (88% had cognitive impairment; 60% had depression). CCRC showed feasibility and initial efficacy in managing PICS. However given its traditional outpatient clinic structure, CCRC has limited physical access to ARF survivors, leading to delayed evaluation and an added travel burden on ARF survivors. Building from the experience of the CCRC and our other successful care coordinator based programs; we now propose a mobile model of post-ICU collaborative care with greater access to enhance the recovery of ARF survivors.

The overarching aim of the proposed program is to improve the QOL of patients who survived an episode of ARF by maximizing their cognitive, physical, and psychological recovery utilizing a mobile care coordinator. The care coordinator will bring the intervention to the patient irrespective of the patient's physical location and will be supported by an interdisciplinary team of a critical care physician, a health services scientist, an ICU nurse, and a psychologist, with input from other consultants as needed. In addition, dynamic feedback through process measurement tools and care coordination support software will inform the recovery process. We propose to evaluate the efficacy of our collaborative care intervention termed the "Mobile Critical Care Recovery Program (m-CCRP)" through a randomized clinical trial among survivors of ARF.

02

Conditions studied

  • Acute Respiratory Failure
  • Post-Intensive Care Syndrome

Keywords

  • Collaborative Care Model
  • Intensive Care Unit
03

In context

postintensive care syndrome

49 studies on the registry are indexed under postintensive care syndrome; 26 are open to participants now.

This study's enrollment of 503 is above the median of 91 across 25 interventional studies indexed under postintensive care syndrome.

Browse postintensive care syndrome studies →

Lead sponsor

Indiana University is the lead sponsor of 982 studies on the registry; 199 are open to participants now.

Of its 148 completed or terminated interventional studies of FDA-regulated products, 117 (79%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • At least 18 years of age
  • Hospitalized in the ICU
  • Diagnosed with Acute Respiratory Failure (ARF) requiring greater than or equal to 24 hours of mechanical ventilation or noninvasive positive pressure ventilation or high flow nasal canula.
  • Discharged to home, skilled nursing facility, sub-acute rehabilitation care, or long-term acute care
  • English speaking
  • Able to consent either in-person or through legally authorized representative
  • Have access to a telephone

Exclusion criteria

Exclusion Criteria:

  • Hospitalized to a regular non-ICU ward
  • Diagnosis of cancer with life expectancy less than 1 year
  • Admitted with ischemic or hemorrhagic cerebrovascular accident, traumatic brain injury, or undergoing neurosurgery
  • History of dementing illnesses and other neurodegenerative disease such as Alzheimer's disease, Parkinson's disease, or vascular dementia
  • Unable to complete study questionnaire due to severe hearing loss
  • Legally blind
  • Pregnant (assessed by urine pregnancy test) or nursing
  • Living outside the greater Indianapolis area
  • Recent history of alcohol or substance abuse
  • Status post tracheostomy and not eligible for a speaking valve
  • Incarcerated at the time of study enrollment
  • Schizophrenia or bipolar disorder (confirmed by EMR)
  • Homelessness
  • Illiterate
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
503 participants (actual)

Study arms

  • Experimental
    Mobile Critical Care Recovery Program

    The group will receive the Mobile Critical Care Recovery Program (m-CCRP) intervention which includes care coordination and collaborative care model for one year post enrollment.

    Behavioral: Mobile Critical Care Program

  • Active comparator
    Attention Control

    The attention control group will receive telephone based check ins related to their health from the research study team.

    Behavioral: Attention Control

Interventions

  • BehavioralMobile Critical Care Program

    The m-CCRP revolves around the central figure of a care coordinator who will organize and align recovery resources. The care coordinator is a registered nurse whose scope of practice includes health coaching, case managing, community organizing, and nursing care provider. The m-CCRP support team will consist of a critical care physician (Dr. Khan), a geriatrician with expertise in collaborative care (Dr. Boustani), an ICU collaborative care nurse (Dr. Lasiter), and a psychologist (Dr. Unverzagt). This team will meet weekly with the care coordinator. Drs. Khan and Boustani will be accessible to the coordinator through phone or pager at all times.

  • BehavioralAttention Control

    Patients in this group will receive regular wellness calls from the research team.

06

What researchers measure

Primary outcomes

  1. Self Reported Quality of Life PCS: Physical Component Score at 1 Year

    Utilizing SF-36 The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) consists of eight domains. It yields two summary scores (PCS: physical component score, and MCS: mental component score). MCS and PCS range from 0 to 100, and higher scores indicate better health status. A difference of 2 or more points is considered clinically meaningful for both the PCS and MCS subscales of SF-36.

    Time frame: 1 year

  2. Self Reported Quality of Life MCS: Mental Component Score at 1 Year

    Utilizing SF-36 The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) consists of eight domains. It yields two summary scores (PCS: physical component score, and MCS: mental component score). MCS and PCS range from 0 to 100, and higher scores indicate better health status. A difference of 2 or more points is considered clinically meaningful for both the PCS and MCS subscales of SF-36.

    Time frame: 1 year

  3. Cognitive Assessment Score at 1 Year

    Utilizing RBANS: Repeatable Battery for the Assessment of Neuropsychological Status. The overall RBANS z-score is the mean of the 7-item (RBANS subscale) z-scores that could be collected in person and by phone. The 7 subscales are: List Learning, Story Memory, Semantic fluency, Digit Span, List Recall, List Recognition, Story Recall. A Z-Score of 0 is the population mean. Values above 0 represent better outcomes.

    Time frame: 1 year

Secondary outcomes

  1. Depression Symptoms at 1 Year

    PHQ-9 (Patient Health Questionnaire-9) Scores range from 0 to 27 on the PHQ-9 with higher scores indicating greater severity of depression.

    Time frame: 1 year

  2. Anxiety Symptoms at 1 Year

    GAD-7 (Generalized Anxiety Disorder-7) Scores range from 0 to 21 on the GAD-7 with higher scores greater anxiety.

    Time frame: 1 year

  3. Physical Performance at 1 Year

    Utilizing SPPB The Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength. Ranges from 0-12: higher score is better outcome

    Time frame: 1 year

07

Results

Posted Jun 24, 2024

Participant flow

Participant flow — Overall Study
MilestoneMobile Critical Care Recovery ProgramAttention Control
Started233233
Completed153147
Not completed8086

Outcome measures

PrimarySelf Reported Quality of Life PCS: Physical Component Score at 1 Year

Utilizing SF-36 The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) consists of eight domains. It yields two summary scores (PCS: physical component score, and MCS: mental component score). MCS and PCS range from 0 to 100, and higher scores indicate better health status. A difference of 2 or more points is considered clinically meaningful for both the PCS and MCS subscales of SF-36.

Time frame:
1 year
Reported as:
Mean · score on a scale
Self Reported Quality of Life PCS: Physical Component Score at 1 Year
score on a scaleMobile Critical Care Recovery ProgramAttention Control
Self Reported Quality of Life PCS: Physical Component Score at 1 Year36.22 ± 12.5535.29 ± 12.20
PrimarySelf Reported Quality of Life MCS: Mental Component Score at 1 Year

Utilizing SF-36 The Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36) consists of eight domains. It yields two summary scores (PCS: physical component score, and MCS: mental component score). MCS and PCS range from 0 to 100, and higher scores indicate better health status. A difference of 2 or more points is considered clinically meaningful for both the PCS and MCS subscales of SF-36.

Time frame:
1 year
Reported as:
Mean · score on a scale
Self Reported Quality of Life MCS: Mental Component Score at 1 Year
score on a scaleMobile Critical Care Recovery ProgramAttention Control
Self Reported Quality of Life MCS: Mental Component Score at 1 Year49.81 ± 11.7551.12 ± 10.23
PrimaryCognitive Assessment Score at 1 Year

Utilizing RBANS: Repeatable Battery for the Assessment of Neuropsychological Status. The overall RBANS z-score is the mean of the 7-item (RBANS subscale) z-scores that could be collected in person and by phone. The 7 subscales are: List Learning, Story Memory, Semantic fluency, Digit Span, List Recall, List Recognition, Story Recall. A Z-Score of 0 is the population mean. Values above 0 represent better outcomes.

Time frame:
1 year
Reported as:
Mean · Z-score
Cognitive Assessment Score at 1 Year
Z-scoreMobile Critical Care Recovery ProgramAttention Control
Cognitive Assessment Score at 1 Year0.27 ± 0.700.26 ± 0.68
SecondaryDepression Symptoms at 1 Year

PHQ-9 (Patient Health Questionnaire-9) Scores range from 0 to 27 on the PHQ-9 with higher scores indicating greater severity of depression.

Time frame:
1 year
Reported as:
Mean · score on a scale
Depression Symptoms at 1 Year
score on a scaleMobile Critical Care Recovery ProgramAttention Control
Depression Symptoms at 1 Year5.94 ± 6.135.66 ± 5.37
SecondaryAnxiety Symptoms at 1 Year

GAD-7 (Generalized Anxiety Disorder-7) Scores range from 0 to 21 on the GAD-7 with higher scores greater anxiety.

Time frame:
1 year
Reported as:
Mean · score on a scale
Anxiety Symptoms at 1 Year
score on a scaleMobile Critical Care Recovery ProgramAttention Control
Anxiety Symptoms at 1 Year5.04 ± 6.084.82 ± 5.25
SecondaryPhysical Performance at 1 Year

Utilizing SPPB The Short Physical Performance Battery (SPPB) will measure physical training effects on balance and strength. Ranges from 0-12: higher score is better outcome

Time frame:
1 year
Reported as:
Mean · score on a scale
Physical Performance at 1 Year
score on a scaleMobile Critical Care Recovery ProgramAttention Control
Physical Performance at 1 Year8.8 ± 3.08.7 ± 2.8

Adverse events

Collected over Participants were assessed for adverse events from the time of informed consent process completion until the end of study participation. This was approximately 1 year if the study was completed.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Mobile Critical Care Recovery Program24/233 (10.3%)0/233 (0%)0/233 (0%)
Attention Control38/233 (16.3%)0/233 (0%)0/233 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)Mobile Critical Care Recovery ProgramAttention ControlTotal
Mean55.2 ± 14.356.9 ± 14.456.1 ± 14.4
Sex: Female, Male
Sex: Female, Male(Participants)Mobile Critical Care Recovery ProgramAttention ControlTotal
Female125125250
Male108108216
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Mobile Critical Care Recovery ProgramAttention ControlTotal
Hispanic or Latino055
Not Hispanic or Latino233228461
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Mobile Critical Care Recovery ProgramAttention ControlTotal
American Indian or Alaska Native202
Asian134
Native Hawaiian or Other Pacific Islander000
Black or African American9478172
White134146280
More than one race011
Unknown or Not Reported257
08

Study locations

3 sites
  • Eskenazi Hospital
    Indianapolis, Indiana 46202, United States
  • Methodist Hospital
    Indianapolis, Indiana 46202, United States
  • University Hospital
    Indianapolis, Indiana 46202, United States
09

References and documents

Publications

  • Ferguson H, Sanjuan A, Perkins AJ, Elias M, Wang S, Mekala SN, Devine B, Koehler Z, Chi R, Gao S, Khan B, Khan S. Relationship Between ICU Delirium and Change in Quality of Life, Mood, and Cognition Over 12 Months in Survivors of Acute Respiratory Failure. CHEST Crit Care. 2026 Mar;4(1):100242. doi: 10.1016/j.chstcc.2026.100242. Epub 2026 Feb 26. PubMed 41938652 ↗
  • Savsani PK, Khan SH, Perkins AJ, Wang S, Jawaid S, Moiz S, Monahan PO, Kroenke K, Gao S, Khan BA. Performance of the Healthy Aging Brain Care Monitor Self Report in Monitoring Post-Intensive Care Syndrome Among Acute Respiratory Failure Survivors. Crit Care Med. 2025 Feb 1;53(2):e341-e352. doi: 10.1097/CCM.0000000000006522. Epub 2024 Nov 11. PubMed 39526840 ↗
  • Khan BA, Perkins AJ, Khan SH, Unverzagt FW, Lasiter S, Gao S, Wang S, Zarzaur BL, Rahman O, Eltarras A, Qureshi H, Boustani MA. Mobile Critical Care Recovery Program for Survivors of Acute Respiratory Failure: A Randomized Clinical Trial. JAMA Netw Open. 2024 Jan 2;7(1):e2353158. doi: 10.1001/jamanetworkopen.2023.53158. PubMed 38289602 ↗
  • Khan S, Biju A, Wang S, Gao S, Irfan O, Harrawood A, Martinez S, Brewer E, Perkins A, Unverzagt FW, Lasiter S, Zarzaur B, Rahman O, Boustani M, Khan B. Mobile critical care recovery program (m-CCRP) for acute respiratory failure survivors: study protocol for a randomized controlled trial. Trials. 2018 Feb 7;19(1):94. doi: 10.1186/s13063-018-2449-2. PubMed 29415760 ↗

Study documents

  • Protocol and statistical analysis plan · Aug 31, 2021
  • Informed consent form · Aug 31, 2021

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No — There is no plan to make individual participant data (IPD) available to other researchers.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2017 to primary completion in Oct 2022, 67 months.

Results were first posted in Jun 2024, 1 year 7 months after primary completion.

Of 21 interventional studies with no phase under postintensive care syndrome, half reached primary completion within 28 months of starting (the median), counting those still running; a quarter within 22 and three quarters within 38. This study's 67 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 1, 2017
First posted
Feb 15, 2017
StartActual
Mar 1, 2017
Primary completionActual
Oct 31, 2022
CompletionActual
Oct 31, 2022
Results first posted
Jun 24, 2024
Last update
Jun 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03053245
Lead sponsor
Indiana University
Responsible party
Babar Khan, MD, MS (Assistant Professor of Medicine Research Scientist, Regenstrief Institute, Inc. Research Scientist, Indiana University Center for Aging Research, Indiana University) — Principal investigator
First posted
Feb 15, 2017
Start date
Mar 1, 2017
Primary completion
Oct 31, 2022
Completion
Oct 31, 2022
Results posted
Jun 24, 2024
Last update
Jun 24, 2024

Study contacts

Babar A Khan, MD, MS
principal investigator · Indiana University Center for Aging Research

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion